The University of Utah has been awarded a $538,998.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 15, 2024, will support the university's research project titled "ENHANCING THE ANTITUMOR MYELOID IMMUNE RESPONSE TO TREAT ADRENOCORTICAL CARCINOMA". The funding will enable the University of Utah to conduct innovative biomedical research aimed at improving treatments for adrenocortical carcinoma, a rare and aggressive form of cancer. The research project is expected to be completed by July 14, 2027. As a prominent research institution, the University of Utah has a strong track record of securing federal grants and contracts to advance scientific knowledge and address critical medical challenges.
Generated 1/28/25, 8:54 AM